This week I’m joined by Dr Hirsh Trivedi, a transplant hepatologist and Director of the Metabolic Liver Program at Dell Medical School, UT Austin. He is board certified four times over, in internal medicine, gastroenterology, transplant hepatology, and obesity medicine, and he spends his clinic days with people who were told for years that their numbers were fine.
Fatty liver is one of the most common and most overlooked metabolic conditions in the world, and you can have it without being overweight. Hirsh explains why the liver sits at the centre of metabolic health, how fat leads to inflammation and scarring, and why that process is not as irreversible as we once thought. We cover the tests worth asking for, the daily habits that move the needle, and where GLP-1 medications, and the grey market versions of them, fit in.
What We Cover
- Why you can have a normal waistline and still be depositing harmful amounts of fat in your liver, and what “lean MASLD” is
- How fat in the liver drives inflammation, scarring and cirrhosis, and why there is no such thing as benign liver fat
- Why cardiovascular disease is the leading cause of death in people with metabolic liver disease
- The tests that matter: fasting insulin, HOMA-IR, ApoB and the simple FIB-4 score, and why ethnicity and family history change how early to screen
- How insulin resistance develops, including the role of the womb environment and genetics
- Why exercise improves liver fat and inflammation independent of weight loss, and why a 10 to 15 minute walk after meals counts
- Why breakfast and lunch should be bigger than dinner, and why eating three to four hours before bed matters
- How sleep, sleep apnoea and stress feed into liver disease, even in lean people
- A plant-predominant, high-fibre, Mediterranean-style way of eating, polyphenols, coffee, and why Hirsh thinks we are becoming too protein obsessed
- Why muscle and gut health are the two best entry points for protecting the liver, and how sarcopenia affects liver transplant outcomes
- GLP-1 medications, muscle loss, weight regain after stopping, semaglutide, tirzepatide, retatrutide and resmetirom
- The dangers of grey market peptides, and why milk thistle and “liver detoxes” do not do what people hope
If you have ever been told your bloodwork looks fine, this conversation will show you what to ask for next. As Hirsh puts it, think of your health as a set of signals you send your biology every day, because the accumulated effect of those signals sets your trajectory.
To connect with Dr Hirsh Trivedi, subscribe to his newsletter at Inherited Risk on Substack, join the email list for his upcoming book at inheritedrisk.org, visit hirshtrivedi.com, and follow him on Instagram as @thelivermd.
Disclosure: Dr Hirsh Trivedi is an advisor to Madrigal Pharmaceuticals and a consultant for Novo Nordisk.
Resources and links:
- Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity
- Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study
- A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
- Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
- A Gastroenterologist’s Approach to Improving Metabolic Health in MASLD
- The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
Subscribe and stay connected:
Subscribe to The Proof on YouTube, Apple Podcasts or Spotify to ensure you never miss an episode. And don’t forget to follow me on Instagram and X for more insights and updates.
This episode is brought to you by:
38TERA
38TERA’s BDR is a clinically dosed gut health supplement for improved digestion, less bloating, better bowel movements and a healthier microbiome. Use code THEPROOF for a discount at checkout.
38Tera ships to the United States, Australia, and New Zealand.
IM8
With 92 nutrients, including Vitamin B12, Iodine, Selenium and Vitamin D, in highly absorbable forms, IM8 Daily Essentials is the perfect all-in-one daily multi-vitamin to ensure you meet your daily micronutrient needs. IM8 is offering an exclusive 10% off your first order with a free welcome kit when you enter the promo code SIMON at checkout on im8health.com.
IM8 ships to 27 countries including the U.S., Canada, the U.K., Australia, and many regions across Europe, Asia, and South America.
Shokz
Shokz OpenFit Pro brings Open-Ear Noise Reduction to open-ear listening, so background noise feels farther away while you stay connected to your surroundings. Head to shokz.com/THEPROOF and use code THEPROOF for a long-term discount on all Shokz products, stackable with other official promotions.
Function Health
Make knowing your health part of your holiday plans. Function gives you access to 160+ lab tests for $365 a year – about a dollar a day. Join at functionhealth.com/SIMONHILL and use code SIMON25 for a $25 credit.
Function Health ships to 48 U.S. states, excluding Rhode Island, Hawai‘i, and Puerto Rico.
WHOOP
Whoop, the most advanced fitness and health wearable available. Your personalised fitness and health coach to recover faster, sleep better, and train smarter. Claim your first month free on join.whoop.com/simon.
Whoop ships to 56+ international markets, including the US, Canada, most of Europe, Australia, New Zealand, UAE, Singapore, and parts of Asia.
More about Hirsh Trivedi
Hirsh Trivedi, MD, MS is a hepatologist and Director of the Metabolic Liver Program at Dell Medical School, UT Austin, where he is Assistant Professor of Medicine and Associate Program Director of the Gastroenterology Fellowship.
He is board certified four times over, in internal medicine, gastroenterology, transplant hepatology, and obesity medicine. He completed internal medicine residency at a Tufts-affiliated hospital in Boston and an NIH-funded T32 fellowship and clinical fellowships in gastroenterology and hepatology, as well as transplant hepatology at Beth Israel Deaconess Medical Center, Harvard Medical School, where he served as Chief Fellow. He holds an MS in Epidemiology from the Harvard T.H. Chan School of Public Health. Before moving to Austin he was on faculty at Cedars-Sinai. He has published more than 85 peer-reviewed papers and multiple textbook chapters.
His clinic is where metabolic disease ends up. Fatty liver, fibrosis, cirrhosis in people who were told for years that their numbers were fine.
He is writing Inherited Risk, a book about why chronic metabolic disease is not a failure of willpower. It is inherited biology meeting an environment it was never built for: genetic variants, developmental programming, and signals passed down across generations. The book follows three generations of his own family alongside the patients who taught him to read those signals, and it organizes prevention around three of them. Glucose stability. Muscle preservation. Inflammatory balance.
He writes at inheritedrisk.substack.com and posts as @thelivermd. He lives in Austin.


